Zion Market Research has published a new report titled “Antithrombin Market by (Source- Human, and Goat Milk; Application – Diagnostics, Therapeutics, and Research; Dosage Form- Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 – 2022”. According to the report, global antithrombin market was valued at approximately USD 450.4 million in 2016 and is expected to generate revenue of around USD 613.8 million by end of 2022, growing at a CAGR of around 5.3% between 2017 and 2022.

Antithrombin is a protein present in the bloodstream, which functions as a naturally occurring mild blood thinner. Antithrombin helps to control too much clotting. A person with low antithrombin levels has more tendency to clot more easily. Vice-versa, if antithrombin levels are too high, a person could, theoretically, have a more bleeding tendency. However, raised levels of antithrombin do not appear to cause bleeding or have any clinical significance.

Year End Sale: Get Flat 30% off on all reports

The widespread use of antithrombin for the treatment of various medical conditions such as extracorporeal membrane oxygenation, hereditary antithrombin deficiency, sepsis, and disseminated intravascular coagulation are the major factors responsible for the growth of global antithrombin market. Moreover, the rising adoption of antithrombin as a combination therapy with heparin is expected to open huge growth opportunities for antithrombin market.

The global antithrombin market is segmented on the basis of source, application, dosage form, and geographically. By source, the antithrombin market has been segmented as human, and goat milk. The human source, the segment is estimated to account major shares in global antithrombin market in 2016. Humans are the major source of antithrombins, but know a day’s the use of goat milk for the production of antithrombin is increasing. Goats produce about 800 liters of milk per year. As compared to cell culture model, the yield of the active protein by goat model is 10 times more. The transgenic goats are the excellent source for antithrombin production, as they produce plenty of milk in short generation time, and these factors are responsible for the high growth of goat milk segment over the forecast period. Currently, the goat milk produced antithrombins are available in developed countries such as U.S., UK, and Germany etc. The increasing adoption of newer technologies and advanced products in developing countries is expected to drive the growth of segment over the forecast period.

Request Free Sample Research Report @ https://goo.gl/McQH43

On the basis of application, the global antithrombin market is segmented into major three types such as diagnostics, therapeutics, and research. By application, the therapeutics segment is estimated to account major share in global antithrombin market. The increasing research and development activities and rising government initiatives for research are expected to drive the growth of research segment globally.

On the basis of the dosage form, the global antithrombin market is segmented as a liquid and lyophilized. The lyophilized dosage form accounted major share in the global market in 2016 and expected to register high CAGR. Lyophilized antithrombins have good shelf-life, easy to handle and, have wide application and these factors are expected to propel the growth of segment over the forecast period.

Browse detail report with in-depth TOC @ https://goo.gl/sV6Nni

(Get this report at discounted price $2939.30)

North America, Europe, Asia-Pacific, Latin America and Middle East & Africa are key regional segments of global antithrombin market. Europe is anticipated to remain the leading region over the forecast period. The rising adoption of antithrombin therapies owing to high awareness in the region is expected to boost the growth of the market in Europe. North America accounted the second position in global antithrombin market. The rising research and development activities in North America, especially in the U.S., is expected to propel the growth of the market in the region over the forecast period. The Asia Pacific is expected to be the fasted growing region in antithrombin market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show considerable growth for this market in the years to come.

For Media Inquiry contact our sales Team @ sales@zionmarketresearch.com

Some of the key players in global Antithrombin market include Grifols, rEVO Biologics Inc., Shire plc., Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., and Lee Biosolutions among others.

About Us: Zion Market Research is an obligated company. We create futuristically, cutting edge, informative reports ranging from industry reports, a company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with Vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from Cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research

4283, Express Lane,

Suite 634-143,

Sarasota, Florida 34249, United States

Tel: +49-322 210 92714

USA/Canada Toll-Free No.1-855-465-4651

Email: sales@zionmarketresearch.com

Website: http://www.zionmarketresearch.com

Visit Our Blog: https://zionmarketresearch.wordpress.com